Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

As the FDA wavers from cuts, changes and departures under the second Trump administration, another vital figure of the agency ...

United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...

A month has gone by since the last earnings report for United Therapeutics (UTHR). Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...

Learn more about whether Alvotech or PTC Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

The upgrade is a reflection of the strong business momentum and substantial deleveraging of Amex GBT since the initial rating assignment in 2024. Moody’s Ratings analyst, Oleg Markin, expects the ...

Chancellor Rachel Reeves says Stoke-on-Trent's struggling ceramics industry will benefit from government investment in ...

Even as the vestige of the waterfront’s industrial past is slated for demolition, the idea of building a new span across the mouth of the Fort Point Channel lives on.

The stock market is waiting on a follow through day. Miami's eMerge Americas conference may provide some surprise energy for ...

Shield AI has announced a collaborative effort with the RSAF and the Defence Science and Technology Agency (DSTA) of Singapore.

Phase 1 MAD dosing completed for SION-451 and final MAD cohort of SION-719 planned; Interim data in healthy volunteers show potential to provide ...